147 related articles for article (PubMed ID: 8382039)
41. Experimental infection of bulls and cows with bluetongue virus serotype 20.
Parsonson IM; Della-Porta AJ; McPhee DA; Cybinski DH; Squire KR; Uren MF
Aust Vet J; 1987 Jan; 64(1):10-3. PubMed ID: 3036056
[TBL] [Abstract][Full Text] [Related]
42. Infection of cattle in Queensland with bluetongue viruses: II. Distribution of antibodies.
Ward MP; Carpenter TE
Aust Vet J; 1995 Jun; 72(6):217-20. PubMed ID: 8526815
[TBL] [Abstract][Full Text] [Related]
43. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
44. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.
Ward RL; Knowlton DR; Schiff GM; Hoshino Y; Greenberg HB
J Virol; 1988 May; 62(5):1543-9. PubMed ID: 3357205
[TBL] [Abstract][Full Text] [Related]
45. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
Pierce CM; Rossitto PV; MacLachlan NJ
Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
[TBL] [Abstract][Full Text] [Related]
46. Immune response to bluetongue virus infection.
Stott JL; Osburn BI
Curr Top Microbiol Immunol; 1990; 162():163-78. PubMed ID: 2166645
[No Abstract] [Full Text] [Related]
47. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
[TBL] [Abstract][Full Text] [Related]
48. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
Hwang GY; Li JK
Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
[TBL] [Abstract][Full Text] [Related]
49. Genome segment reassortment between two serotypes of bluetongue virus in a natural host.
Stott JL; Oberst RD; Channell MB; Osburn BI
J Virol; 1987 Sep; 61(9):2670-4. PubMed ID: 3039160
[TBL] [Abstract][Full Text] [Related]
50. A comparison of six different bluetongue virus isolates by cross-hybridization of the dsRNA genome segments.
Mertens PP; Pedley S; Cowley J; Burroughs JN
Virology; 1987 Dec; 161(2):438-47. PubMed ID: 2825416
[TBL] [Abstract][Full Text] [Related]
51. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
[TBL] [Abstract][Full Text] [Related]
52. Genetic stability in calves of a single strain of bluetongue virus.
MacLachlan NJ; Fuller FJ
Am J Vet Res; 1986 Apr; 47(4):762-4. PubMed ID: 3008608
[TBL] [Abstract][Full Text] [Related]
53. Neutralizing epitopes of the serotypes of bluetongue virus present in the United States.
Rossitto PV; MacLachlan NJ
J Gen Virol; 1992 Aug; 73 ( Pt 8)():1947-52. PubMed ID: 1379625
[TBL] [Abstract][Full Text] [Related]
54. Bluetongue virus-induced interferon in cattle.
MacLachlan NJ; Thompson J
Am J Vet Res; 1985 Jun; 46(6):1238-41. PubMed ID: 2411172
[TBL] [Abstract][Full Text] [Related]
55. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
Roy P; Bishop DH; LeBlois H; Erasmus BJ
Vaccine; 1994 Jul; 12(9):805-11. PubMed ID: 7975859
[TBL] [Abstract][Full Text] [Related]
56. Serologic responses of calves to sequential infections with epizootic hemorrhagic disease virus serotypes.
Bowen RA
Am J Vet Res; 1987 Oct; 48(10):1449-52. PubMed ID: 2823649
[TBL] [Abstract][Full Text] [Related]
57. Emergence of multireassortant bluetongue virus serotype 4 in Hungary.
Hornyák Á; Malik P; Marton S; Dóró R; Cadar D; Bányai K
Infect Genet Evol; 2015 Jul; 33():6-10. PubMed ID: 25847695
[TBL] [Abstract][Full Text] [Related]
58. Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.
Breard E; Garnier A; Despres P; Blaise Boisseau S; Comtet L; Viarouge C; Bakkali-Kassimi L; Pourquier P; Hudelet P; Vitour D; Rossi S; Belbis G; Sailleau C; Zientara S
Transbound Emerg Dis; 2017 Dec; 64(6):1837-1847. PubMed ID: 27667484
[TBL] [Abstract][Full Text] [Related]
59. The occurrence of antibody to bluetongue virus in New South Wales. I. Statewide surveys of cattle and sheep.
Burton RW; Littlejohns IR
Aust J Biol Sci; 1988; 41(4):563-70. PubMed ID: 2856014
[TBL] [Abstract][Full Text] [Related]
60. Unusual observations on a serologically negative bluetongue virus infected bull.
Schultz RD; Rhodes P; Panangala VS; Kaproth M
Prog Clin Biol Res; 1985; 178():97-102. PubMed ID: 2989933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
